ZOOM

Dr Carolyn Owen from the Tom Baker Cancer Centre in Calgary will be the speaker at our upcoming National Zoom meeting.  Her topic is “After Bendamustine and Rituxan ... then what?”. Dr. Owen is Professor in the Division of Hematology & Hematological Malignancies, University of Calgary, and Hematologist at the Tom Baker Cancer Centre.  She is also the Lead Investigator at the Tom Baker Cancer Centre for the clinical trial of Nemtabrutinib, which we have reported on. As the title says, she will be talking about what follows the standard first-line treatment in Canada, which is, typically, Bendamustine+Rituximab.  But for a [...]